Ex Parte FUCHS et al - Page 9




         Appeal No. 2001-0936                                                       
         Application No. 08/952,208                                                 
         discolorations or imperfections could result in the loss of an             
         entire batch.  (Appeal Brief, page 6, lines 25-37).                        
              The appellants further contend that Ritz itself teaches away          
         from the claimed 0.01% THA-1 in that at column 8, lines 22-29              
         teaches that some impurities in concentrations of 10 ppm or less           
         can “make it impossible to adhere to characteristics.”                     
              Additionally, the declaration of Melder (Paper #13, page 5,           
         first full paragraph) states that purification of 6-                       
         aminocapronitrile in Ritz must have occurred upon its                      
         manufacture, based upon the three cited references in Ritz.  The           
         appellants urge that these three references either state or imply          
         that the resulting 6-ACN is distilled off (Id., page 4, lines 17-          
         37) and is therefore “pure” in the sense of free from THA-1.  The          
         appellants have also stated that this is so because in the                 
         appropriate work-up to distill off the 6-CAN, THA-1 would be left          
         in the residue unless the distillation were continued.  (Id.,              
         page 3, last two paragraphs).                                              
              Furthermore, the appellants have asserted that in the art of          
         manufacturing caprolactam or polycaprolactam for manufacture               
         into, e.g. nylon 6, it is generally known to use pure materials            
         to avoid wasting a batch of product. (Appeal Brief, page 6,                
         second paragraph).                                                         


                                         9                                          





Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next 

Last modified: November 3, 2007